Biogen (BIIB) FCF Margin (2009 - 2026)
Biogen (BIIB) recorded quarterly FCF Margin of 23.98% in Q1 2026, up 16.82% quarter-over-quarter from 20.53% in Q4 2025, and up 1484.0% on a YoY basis from 1.51% in Q1 2025.
Biogen (BIIB) FCF Margin (2009 - 2026) Analysis & Trends
Biogen's FCF Margin history runs 18 years deep, the most recent figure standing at 23.98% for Q1 2026.
- In Q1 2026, FCF Margin rose 1484.0% year-over-year to 23.98%; the TTM figure through Mar 2026 stood at 24.38% (down 44.0% YoY), while the FY2025 annual figure was 20.73%, down 739.0% from the prior year.
- FCF Margin was 23.98% for Q1 2026 at Biogen, up from 20.53% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 48.38% in Q3 2025 to a low of 10.28% in Q4 2022.
- Historically, FCF Margin has averaged 18.53% across 5 years, with a median of 20.53% in 2025.
- The sharpest annual moves came in 2022 and 2024: FCF Margin plunged 3905 bps in 2022, then soared 3161 bps in 2024.
- A 5-year view of FCF Margin shows it stood at 10.28% in 2022, then jumped by 79 bps to 2.21% in 2023, then soared by 1431 bps to 29.4% in 2024, then plunged by 30 bps to 20.53% in 2025, then advanced by 17 bps to 23.98% in 2026.
- The last three FCF Margin figures came in at 23.98% (Q1 2026), 20.53% (Q4 2025), and 48.38% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 20.59% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 15.19% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 6.09% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 23.76% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 17.97% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 17.14% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 34.87% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 93.16% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 6.59% |
| 10 | Biogen | 28.75 Bn | 24.47 Bn | 1.82 Bn | 23.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.98% |
| Dec 31, 2025 | 20.53% |
| Sep 30, 2025 | 48.38% |
| Jun 30, 2025 | 5.08% |
| Mar 31, 2025 | 9.14% |
| Dec 31, 2024 | 29.40% |
| Sep 30, 2024 | 36.52% |
| Jun 30, 2024 | 24.03% |
| Mar 31, 2024 | 22.15% |
| Dec 31, 2023 | -2.21% |
| Sep 30, 2023 | 20.48% |
| Jun 30, 2023 | 16.94% |
| Mar 31, 2023 | 15.78% |
| Dec 31, 2022 | -10.28% |
| Sep 30, 2022 | 23.99% |
| Jun 30, 2022 | 27.02% |
| Mar 31, 2022 | 4.10% |
| Dec 31, 2021 | 28.78% |
| Sep 30, 2021 | 27.47% |
| Jun 30, 2021 | 41.64% |